DOPAMINE D(2) RECEPTORS IN DEPRESSION MEASURED WITH SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

被引:147
作者
DHAENEN, HA [1 ]
BOSSUYT, A [1 ]
机构
[1] FREE UNIV BRUSSELS, ACAD HOSP, DEPT NUCL MED, B-1090 BRUSSELS, BELGIUM
关键词
D-2; RECEPTORS; DEPRESSION; SPECT;
D O I
10.1016/0006-3223(94)91202-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Psychobiological theories of mood disorders have been concerned mainly with noradrenaline and serotonin. There exists, however, a recent upsurge of interest in dopamine. We have used single photon emission computed tomography and I-123-iodobenzamide, a high-affinity ligand for D-2 receptors, to study these receptors in depression. Subjects were 21 (unipolar) depressed inpatients and II normal controls. The mean basal ganglia/cerebellum uptake ratio was 1.94 (+/- 0.27) in the depressed patients versus 1.74 (+/- 0.17) in the controls. This difference was statistically significant (Mann-Whimey U test, p = 0.025). These data could indicate an increase of D-2 receptor density in depression.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 27 条
  • [1] [Anonymous], 1975, CURRENT DEV PSYCHOPH
  • [2] LACK OF EFFECT OF REPEATED ELECTROCONVULSIVE SHOCK ON [H-3]SPIROPERIDOL AND [H-3]5-HYDROXYTRYPTAMINE BINDING AND CHOLINERGIC PARAMETERS IN RAT-BRAIN
    ATTERWILL, CK
    [J]. JOURNAL OF NEUROCHEMISTRY, 1980, 35 (03) : 729 - 734
  • [3] BAXTER LR, 1985, ARCH GEN PSYCHIAT, V42, P441
  • [4] BECH P, 1989, MINI COMPENDIUM RATI
  • [5] EFFECT OF ELECTROCONVULSIVE SHOCK ON MONO-AMINERGIC RECEPTOR-BINDING SITES IN RAT-BRAIN
    BERGSTROM, DA
    KELLAR, KJ
    [J]. NATURE, 1979, 278 (5703) : 464 - 466
  • [6] BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220
  • [7] FRONTAL-CORTEX AND BASAL GANGLIA METABOLIC RATES ASSESSED BY POSITRON EMISSION TOMOGRAPHY WITH [F-18] 2-DEOXYGLUCOSE IN AFFECTIVE-ILLNESS
    BUCHSBAUM, MS
    WU, J
    DELISI, LE
    HOLCOMB, H
    KESSLER, R
    JOHNSON, J
    KING, AC
    HAZLETT, E
    LANGSTON, K
    POST, RM
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1986, 10 (02) : 137 - 152
  • [8] Jimerson DC, 1987, PSYCHOPHARMACOLOGY 3, P505
  • [9] KONIG P, 1991, BIOL PSYCHIAT, V29, pA173
  • [10] KUNG HF, 1990, J NUCL MED, V31, P573